Articles by Disease (Chronic Peptic Ulcer)

Flavonoids: A Review of Its Commercial Application Potential as Anti- Infective Agents

Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 2
Page: 335-353
Author(s): J. C. Pretorius

Dual COX Inhibition and Upper Gastrointestinal Damage

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2191-2195
Author(s): M. M. Skelly and C. J. Hawkey

Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2197-2206
Author(s): James M. Scheiman

Mucosal Repair and COX-2 Inhibition

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2207-2211
Author(s): Rafael F. Perini, Li Ma and John L. Wallace

COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2213-2219
Author(s): Francis K.L. Chan

COX-2 Inhibition Versus Gastroprotection with Dual COX Inhibitors: An Evidence-Based Approach

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2221-2228
Author(s): Alexander J.V. Thompson and Neville D. Yeomans

Cyclooxygenase-2 Inhibition and Gastric Cancer

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2281-2288
Author(s): Xiao Hua Jiang and C. Y. Wong

β3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3
Page: 257-273
Author(s): E. Nisoli, C. Tonello and M. O. Carruba

The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1715-1732
Author(s): Sunil Nadar and Gregory Y.H. Lip

Biodefense Properties of Milk: The Role of Antimicrobial Proteins and Peptides

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1239-1255
Author(s): D. A. Clare, G. L. Catignani and H. E. Swaisgood